Detalhe da pesquisa
1.
High patient satisfaction and increased physical activity following a remote multidisciplinary team multiple myeloma clinic.
Support Care Cancer
; 31(2): 127, 2023 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36680643
2.
Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis.
Eur J Haematol
; 104(3): 230-235, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31815313
3.
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
Br J Haematol
; 187(5): 638-641, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31388995
4.
Brain magnetic resonance imaging review suggests unrecognised hypoglycaemia in childhood.
Front Endocrinol (Lausanne)
; 15: 1338980, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38616820
5.
First Accuracy and User-Experience Evaluation of New Continuous Glucose Monitoring System for Hypoglycemia Due to Hyperinsulinism.
J Diabetes Sci Technol
; : 19322968241245923, 2024 Apr 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38616550
6.
Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus.
Front Endocrinol (Lausanne)
; 14: 1231043, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38027197
7.
A survey tool for measuring evidence-based decision making capacity in public health agencies.
BMC Health Serv Res
; 12: 57, 2012 Mar 09.
Artigo
Inglês
| MEDLINE | ID: mdl-22405439
8.
Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis.
Amyloid
; 27(3): 200-205, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32408823
9.
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
Blood Cancer J
; 12(9): 128, 2022 09 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36064540